Article: Discovery Biotech Files Registration Statement with the United States Securities Exchange Commission. (SEC); Document Control Number: 34SSR-002-07.

BURLINGTON, ON -- BURLINGTON, ON, April 17 /PRNewswire/ -- Discovery Biotech Files Registration Statement with the United States Securities Exchange Commission. (SEC)

Discovery Biotech is pleased to announce that it has filed a Form 1-A registration statement with the Securities Exchange commission. The current file proposes the registration to raise $5,000,000 USD via the sale of 400,000 shares of its common stock with a proposed offering price of $12.50 USD through an Initial Public Offering. The company warns readers that this in no way means the company has been listed or approved for listing on any exchange.

The Companys' President, Bernard ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!